These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23587702)

  • 1. Does the current treatment of invasive fungal infection need to be reviewed?
    Martín-Peña A; Aguilar-Guisado M; Cisneros JM
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):523-8. PubMed ID: 23587702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.
    Mikolajewska A; Schwartz S; Ruhnke M
    Mycoses; 2012 Jan; 55(1):2-16. PubMed ID: 21554421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antifungal therapy in patients with febrile neutropenia.
    Ferrara JJ; MacDougall C; Gallagher JC
    Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of invasive fungal diseases in neutropenic patients.
    Almyroudis NG; Segal BH
    Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of invasive fungal infections in neutropenic patients.
    Akan H
    Hematology; 2005; 10 Suppl 1():234-7. PubMed ID: 16188681
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
    Almyroudis NG; Segal BH
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Fungal Infections in the Intensive Care Unit.
    Ostrosky-Zeichner L; Al-Obaidi M
    Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of invasive mycoses in hematology patients: current approaches.
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders.
    Hayes-Lattin B; Maziarz RT
    Leuk Lymphoma; 2004 Apr; 45(4):669-80. PubMed ID: 15160938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive fungal infection in haematology patients].
    Vallejo Llamas JC; Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
    Coyle EA
    J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.